ARCHIVES

Letters: Kopans To Broder: Response Ignores Major Questions

This article is from The Cancer Letter archive.

Vol. 19 No. 40 | October 15, 1993

Download PDF Visit The Full Archive

Related Articles

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

October 9, 1987

Nelvis Castro To Serve As Acting OCC Chief; HHS Selects ANA President Malone.

January 7, 2000

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

June 30, 2000

NIh Clinical Center Urged To Create Governing Board

March 15, 1996

Clinton Budget For NIH “Disappointing,” AACR executive Director Says

May 7, 1993